A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy
Clinical trial NCT06354868 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06354868
- Sponsor
- Neuronostics Ltd
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-12-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.